In order to get new insights on the mechanism of expression of these genes we intended to define the correlation between CT7 and CT10 expression and the presence of activating KIT mutations; this is based on the frequent activation of the KIT gene in MM and the finding that an activated KIT may allow MAGE gene expression in mast cell leukemia [27]. This evidence concerns the gene MAGEC2 and mast cell leukemia.